HBIO vs PGR · rev $22.7M vs P/E 10, rev $45.80B
Harvard Bioscience Inc (HBIO) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
Latest reported PGR revenue for 2026-06-30 was $45.80B. Net income was $6.13B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
HBIO currently screens at market cap $20.3M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the HBIO and PGR stock pages for the full models.
Not investment advice.